Literature DB >> 35170741

A Retrospective Study of 105 Patients with Elastolytic Giant Cell Granuloma and a Proposal for a New Clinical Classification.

Yue-Tong Qian, Jia-Wei Liu, Wei Liu, Tian Chen, Yan Tan, Dong-Lai Ma1.   

Abstract

Elastolytic giant cell granuloma, an idiopathic granulomatous dermatosis, is characterized by annular plaques on sun-exposed areas, and has been termed actinic granuloma or annular elastolytic giant cell granuloma. Many atypical clinical manifestations and lesions involving sun-protected areas have been reported. The aims of this retrospective study of 105 patients were to summarize the clinical and histological features of patients with this condition; to provide evidence for the viewpoint that elastolytic giant cell granuloma is a better term to include all clinical morphological types presenting with elastolysis, elastophagocytosis, and an infiltrate of multinucleated giant cells histologically; and to establish a new clinical classification. The varying clinical manifestations were further categorized into annular, papular, giant, mixed and generalized forms. The pathological manifestations were classified into giant cell, necrobiotic, histiocytic, sarcoidal and mixed patterns. Diabetes mellitus or impaired glucose tolerance were the most commonly identified comorbidities. Oral low-dose corticosteroid may be an effective treatment.

Entities:  

Mesh:

Year:  2022        PMID: 35170741      PMCID: PMC9574680          DOI: 10.2340/actadv.v102.1985

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  25 in total

1.  Papular elastolytic giant cell granuloma: report of a case associated with monoclonal gammopathy and responsive to topical tacrolimus.

Authors:  F Rongioletti; M Baldari; M Burlando; A Parodi
Journal:  Clin Exp Dermatol       Date:  2009-04-11       Impact factor: 3.470

2.  Image Gallery: A reticular variant of actinic granuloma.

Authors:  Y-T Qian; J-W Liu; W Liu; D-L Ma
Journal:  Br J Dermatol       Date:  2019-07-15       Impact factor: 9.302

3.  Annular elastolytic giant cell granuloma: mysterious enlarging scarring lesions.

Authors:  Sabrina R Szabo; Colby Fernelius; Navin Arora
Journal:  Cutis       Date:  2019-01

Review 4.  Elastolytic Actinic Giant Cell Granuloma.

Authors:  Enrique Gutiérrez-González; Manuel Pereiro; Jaime Toribio
Journal:  Dermatol Clin       Date:  2015-05-13       Impact factor: 3.478

5.  Annular elastolytic giant cell granuloma: sparing of a burn scar and successful treatment with chloroquine.

Authors:  E Ozkaya-Bayazit; N Büyükbabani; C Baykal; A Oztürk; M Okçu; H P Soyer
Journal:  Br J Dermatol       Date:  1999-03       Impact factor: 9.302

6.  Annular elastolytic giant cell granuloma associated to late-onset X-linked dominant protoporphyria.

Authors:  Francisco Javier García-Martínez; Enrique Gutiérrez-González; Julio Alonso-González; Ana Vega; Marta Santamariña; María Teresa Rodríguez-Granados; Jaime Toribio
Journal:  Dermatology       Date:  2013-10-15       Impact factor: 5.366

7.  Elastolytic giant cell granuloma: clinic-pathologic review of twenty cases.

Authors:  Enrique Gutierrez-Gonzalez; Silvia Gomez-Bernal; Adriana Alvarez-Perez; Dolores Sanchez-Aguilar; Jaime Toribio
Journal:  Dermatol Online J       Date:  2013-10-16

8.  Strict Anatomical Colocalization of Vitiligo and Elastolytic Granulomas.

Authors:  N Merino de Paz; M Rodríguez-Martín; M García Bustínduy; A Martín-Herrera; A Noda-Cabrera
Journal:  Case Rep Dermatol       Date:  2010-02-05

Review 9.  Infiltrated papules on the trunk and headaches: A case of actinic granuloma and a review of the literature.

Authors:  Sonal A Parikh; Syril Keena T Que; William D Holmes; Katalin Ferenczi; Jane M Grant-Kels; Marti Jill Rothe
Journal:  Int J Womens Dermatol       Date:  2015-09-09

10.  Actinic granuloma presenting as tender, linear plaques on the lateral fingers in a patient with newly diagnosed esophageal cancer.

Authors:  Timothy C Michaelis; Jamie L Woodcock; Katherina Kobraei Basic
Journal:  JAAD Case Rep       Date:  2017-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.